SCHEMBL3222838

SCHEMBL3222838

CCn1c2ccccc2c2cc(/C=C/C(=O)CC(=O)/C=C/c3ccc(O)cc3)ccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.62
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 5/20 0.62
SMN1; SMN2 Q16637 5/20 0.62
MAPT P10636 5/20 0.62
POLB P06746 4/20 0.62
HPGD P15428 4/20 0.62
RCE1 Q9Y256 1/20 0.62
KDM4E B2RXH2 5/20 0.55
PKM P14618 1/20 0.55
HTT P42858 1/20 0.55
LMNA P02545 4/20 0.54
SRC P12931 4/20 0.53
AKR1B10 O60218 1/20 0.52
AKR1B1 P15121 1/20 0.52
MAOB P27338 1/20 0.52
PTGS2 P35354 1/20 0.52
GLO1 Q04760 1/20 0.52
CAMK2A Q9UQM7 1/20 0.52
BACE1 P56817 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222846 1.00 MEN1 (0.62) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL3221537 0.94 KDM4E (0.61) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL3221525 0.94 KDM4E (0.61) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL25196371 0.87 KMT2A (0.64) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL30382952 0.87 KMT2A (0.64) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL29641676 0.85 KDM4E (0.63) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL12244182 0.85 KDM4E (0.63) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL3223029 0.85 APP (0.65) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL3223038 0.85 APP (0.65) MEN1KMT2AALDH1A1MAPTPOLB
SCHEMBL3205896 0.85 MAPT (0.60) MEN1KMT2AALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 MEN1 2360/4885KMT2A 2031/4885ALDH1A1 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.